×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
SK bioscience Receives WHO Prequalification for Typhoid Conjugate Vaccine
CVS Pharmacy® announces new simplified loyalty experience
04 Jan 2024
CVS Pharmacy®, the retail division of CVS Health® (NYSE: CVS), today announced the evolution of
...
Developing innovative production technology for the commercialization of 3D cell products, PHC and Cyfuse collaborate
ONFAB, High Potent Containment Provider, Expands into USA Market
Bruker Launches Transformative neofleX MALDI-TOF System
enGene to Showcase Pivotal Phase 1/2 LEGEND Study Details of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
FoundationOne® Diagnostics Approved for TALZENNA®–XTANDI® Therapy
By
Foundation Medicine
Foundation Medicine
01 Jun 2026
BrainStorm Cell Therapeutics appoints Peter J. Pitts to its board.
By
rainStorm Cell Therapeutics Inc.
rainStorm Cell Therapeutics Inc.
28 May 2026
Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe
By
Nestlé Health Science U.S.
Nestlé Health Science U.S.
28 May 2026
Ori Biotech and ImmuXell Announce Strategic Partnership and First Patient Dosed
By
Ori Biotech
Ori Biotech
27 May 2026
SK bioscience Signs Technology Transfer Agreement with Colombia’s VECOL to Advance Local Vaccine Manufacturing in Latin America
By
SK bioscience
SK bioscience
27 May 2026
Presentations Highlight Results on LEROCHOL® (lerodalcibep-liga) Announced by LIB Therapeutics
By
LIB Therapeutics Inc.
LIB Therapeutics Inc.
27 May 2026
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
CollPlant expands its distribution capabilities for rhCollagen in the United States and Canada
By
CollPlant
Oct 28
Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy
By
Factor Bioscience
Apr 23
Datar Cancer Genetics will provide groundbreaking video-enhanced results of in-vitro chemotherapy effectiveness tests for cancer patients
By
Datar Cancer Genetics
Jan 31
June
2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe to Our Monthly Newsletter
Subscribe to Pharmaceutical Era’s monthly newsletter,
Pharmaceutical Leaders Digest
®, to receive timely updates from across the pharmaceutical industry.
I agree with the
Terms and conditions
×
and the
Privacy policy
×
Please enable the javascript to submit this form
Subscribe
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand
